Literature DB >> 8169587

Vascular endothelium in sepsis and endotoxemia.

C H Baker1.   

Abstract

Since septic or endotoxin shock was high mortality and morbidity, mechanisms for cardiovascular collapse have been intensely investigated. The vascular response to catecholamines and other agonists is greatly attenuated. The mechanisms are considered to be related to changes in endothelium function. The endothelium releases vasoconstrictor and vasodilator compounds. These autocoids normally interact with systemic and other local vascular controls, but during endotoxemia this balance is severely altered. Large artery endothelia are destroyed whereas the microvessels remain intact and functional. The release of nitric oxide, prostacyclin and endothelin is greatly enhanced. The cytokines from endotoxin seem, however, to be the major causal agents of the syndrome and affect the endothelial or receptors on the endothelia differentially, dependent on tissue location.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169587

Source DB:  PubMed          Journal:  J Fla Med Assoc        ISSN: 0015-4148


  3 in total

1.  Reduction of electrical coupling between microvascular endothelial cells by NO depends on connexin37.

Authors:  Rebecca L McKinnon; Michael L Bolon; Hong-Xing Wang; Scott Swarbreck; Gerald M Kidder; Alexander M Simon; Karel Tyml
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

2.  Induction of endothelium-dependent constriction of mesenteric arteries in endotoxemic hypotensive shock.

Authors:  Tzu-Ling Tseng; Mei-Fang Chen; Chin-Hung Liu; Cheng-Yoong Pang; Yung-Hsiang Hsu; Tony J F Lee
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

3.  Long term outcomes following hospital admission for sepsis using relative survival analysis: a prospective cohort study of 1,092 patients with 5 year follow up.

Authors:  Joshua S Davis; Vincent He; Nicholas M Anstey; John R Condon
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.